 |
|
|
|
|
 |
Last Updated: Nov 1, 2009 - 11:48:48 PM |
Latest Research
:
Pharmacology
:
Anti-Inflammatory
:
Rofecoxib
Prospective trial confirms Rofecoxib's cardiovascular risks
The trial, known as APPROVe (Adenomatous Polyp Prevention on Vioxx), was the longest test yet of Vioxx as a chemoprevention agent, and was designed to determine whether the drug could prevent the re-growth of precancerous colon polyps in people who had already had polyps removed. The prospective chemoprevention study randomized 2,586 participants from 108 centers in 29 countries to receive either 25 mgs. of Vioxx daily or a placebo drug for three years, 2001-2004. The trial was stopped September 30, 2004 - approximately two months before its planned completion.
Feb 16, 2005 - 3:21:38 PM
|
<< prev
next >>
|
|
|
|
| Health |
Best way to boost adult immunizations is through office-based action, study finds
|
'Pep talk' can revive immune cells exhausted by chronic viral infection
|
Burning more sugar drives super athleticism
|
Research aims to prevent obesity by reaching parents, young children through child care
|
AMD-like lesions delayed in mice fed lower glycemic index diet
|
Low vitamin C levels may raise heart failure patients' risk
|
Sugar-sweetened beverages may increase cardiovascular risk in women
|
Study finds shifting disease burden following universal Hib vaccination
|
UT study: Climate change affects ants and biodiversity
|
Dirt prevents allergy
|
| | Healthcare |
Fitness club memberships help insurance plans to enrol healthier patients
|
Anxiety disorders mount since credit crunch
|
Doctors diagnose patients within moments of meeting
|
Physician-defined patient complexity differs from current diagnosis-based measures
|
Free health screening for school children Nov 14
|
Systematic bias in the assessment of UK doctors
|
White children far more likely to receive CT scans than Hispanic, African-American children
|
Suspected brain disease kills 51 kids in Bihar
|
New rules for bio-medical waste management in India
|
Delhi hospitals lacking in emergency protocols
|
| | Latest Research |
New device performs better than old for removing blood clots
|
Gene related to fat preferences in humans found
|
Cardiovascular Nursing Spring Meeting
|
The effect of occasional binge drinking on heart disease and mortality among moderate drinkers
|
ORNL, partners earn FLC honor for cookstove technology
|
Clot-busting drugs appear safe for treating 'wake-up' stroke patients
|
Infections in childhood linked to high risk of ischemic stroke
|
Penn State scientists elected to American Geophysical Union
|
Wayne State University project aims to reduce HIV, AIDS among African-Americans
|
Scientists help define structure of exoplanets
|
| | Medical News |
Women delivers baby near lift in Noida hospital
|
Obesity on rise in school children: Study
|
Over 10,000 dengue cases in India this year
|
NRI doctors demands removal of 'tainted' medical council members
|
Watch out for sexually transmitted 'superbug': Expert
|
Panel stresses on infection control in hospitals
|
Healthcare cost up 22 times in rural areas, shows study
|
Superbug exists, but nothing alarming: Walia
|
No power problem at AIIMS: Official
|
40 percent Indians embarrassed to ask for contraceptives
|
| | Special Topics |
Behold India's unfolding democratic revolution
|
Chinese woman cuts open her belly to save surgery cost
|
Improved Sense of Smell Produced Smarter Mammals
|
Two-year-old world's first to have extra DNA strand
|
172,155 kidney stones removed from one patient!
|
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
3,000 Kerala medical students to attend inter-college meet
|
Tamil Nadu seeks to control deemed universities
|
|
|
